西拉普利是一种单乙酯,可作为血管紧张素转化酶(ACE)抑制剂。该抑制剂通过抑制ACE裂解血管紧张素I和Hip-His-Leu的键的功能发挥作用。已知西拉普利的二酸形式在抑制ACE方面比依那普利更有效。已知西拉普利被非特异性酯酶水解成其活性酸代谢物西拉普利拉。 产品应用: 西拉普利是一种血管紧张素转换酶 (ACE) 抑制剂,用于治疗高血压和充血性心力衰竭的药物的研究。 Cilazapril is a monoethyl ester, which acts as an angiotensin-converting enzyme (ACE) inhibitor. The inhibitor functions by inhibiting the the ability of ACE to cleave bonds of angiotensin I and Hip-His-Leu. It is known that the diacid form of Cilazapril is more potent that enalapril at inhibiting ACE. It is known that Cilazapril is hydrolyzed to its active acid metabolite, Cilazaprilat by non-specific esterases.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Cilazapril
Dangerous GoodsCAS number:88768-40-5 molecular formula:C22H31N3O5
overview
compound introduction
Specs
| Chinese alias | 抑平舒 | ||
| English alias | D07699 | NCGC00182039-01 | 6H-PYRIDAZINO(1,2-A)(1,2)DIAZEPINE-1-CARBOXYLIC ACID, 9-((1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)AMINO)OCTAHYDRO-10-OXO-, MONOHYDRATE, (1S-(1.ALPHA.,9.ALPHA.(R*))) | DTXCID8028555 | Ro 34-2848 | 8Q9454114Q | (1S,9S)-9-[[(1S)-1-(Ethox | ||
| CAS number | 88768-40-5 | molecular formula | C22H31N3O5 |
| molecular weight | 417.5 g/mol | Exact mass | - |
| PSA | 99.200 Ų | logp | 0.6 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS08
Signal word:
Warning
Hazard Statement:
H361: 怀疑破坏生育力或未出生的孩子
Statement of Preventive Measures:
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P203: 使用前,获取、阅读并遵守所有安全说明。 P318: 如果暴露或担心,请就医。
RTECS:
MJ9650200
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





